for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Markets News

BRIEF-Kane Biotech Reports Qtrly Loss Per Share (Post Consolidation) $0.011

May 17 (Reuters) - Kane Biotech Inc:

* KANE BIOTECH ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS, GRANTING OF OPTIONS AND INVESTOR RELATIONS IMPROVEMENTS

* KANE BIOTECH INC QTRLY LOSS PER SHARE (POST CONSOLIDATION) $0.011 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up